Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
165 participants
OBSERVATIONAL
2012-01-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Investigation Into the Relationship Between Dietary Intake and Health-related Quality of Life in Children and Young People With Juvenile Idiopathic Arthritis
NCT04903067
Yoga Therapy for Adolescents With Juvenile Idiopathic Arthritis
NCT03286933
Pain in Juvenile Arthritis
NCT07217782
Comorbidity Management in Rheumatic Disease.
NCT06579222
Representation and Medication Use in Juvenile Idiopathic Arthritis
NCT03892135
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims of this registry protocol are:
* To create and maintain a secure online database of patients with JIA
* To collect data elements related to cost of care in patients with JIA
* Compare standard outcome and disease activity measures to health care expenditures in JIA
* To determine methods by which to reduce costs while improving outcomes and quality of care
The study plans to enroll 300 or more subjects from 3 medical centers in the US over a 24 month period. Subjects in the study are patients with Juvenile Idiopathic Arthritis.
Enrollment into the protocol will include key demographic and clinical data including, medication exposures, disease severity, and function including disease-specific data elements; and estimates of health care service utilization and health care expenditures. Data will be collected once per subject within the context of a standard of care visit.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person providing consent must be able to read English.
* Subject (and/or parent/legal guardian) is able to provide informed consent and willing to comply with study procedures.
Exclusion Criteria
* Coexisting rheumatologic disorder
* Diagnosis of fibromyalgia
* Participation in a drug trial in the past 6 months.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Cleveland Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Zeft
Director, Center for Pediatric Rheumatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Zeft, MD
Role: PRINCIPAL_INVESTIGATOR
Cleveland Clinic Children's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital & Medical Center
Omaha, Nebraska, United States
The Cleveland Clinic
Cleveland, Ohio, United States
Dell Childrens Medical Center of Central Texas
Austin, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCF 11-291
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.